CH605619A5 - - Google Patents

Info

Publication number
CH605619A5
CH605619A5 CH257777A CH257777A CH605619A5 CH 605619 A5 CH605619 A5 CH 605619A5 CH 257777 A CH257777 A CH 257777A CH 257777 A CH257777 A CH 257777A CH 605619 A5 CH605619 A5 CH 605619A5
Authority
CH
Switzerland
Application number
CH257777A
Inventor
Pierre Vanhoof
Pierre Clarebout
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Publication of CH605619A5 publication Critical patent/CH605619A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH257777A 1973-03-02 1974-03-01 CH605619A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1030473A GB1468347A (en) 1973-03-02 1973-03-02 Aminoindanes

Publications (1)

Publication Number Publication Date
CH605619A5 true CH605619A5 (xx) 1978-09-29

Family

ID=9965409

Family Applications (3)

Application Number Title Priority Date Filing Date
CH257777A CH605619A5 (xx) 1973-03-02 1974-03-01
CH297474A CH593909A5 (xx) 1973-03-02 1974-03-01
CH257877A CH593910A5 (xx) 1973-03-02 1974-03-01

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH297474A CH593909A5 (xx) 1973-03-02 1974-03-01
CH257877A CH593910A5 (xx) 1973-03-02 1974-03-01

Country Status (16)

Country Link
JP (1) JPS547789B2 (xx)
AR (3) AR204526A1 (xx)
AT (1) AT333742B (xx)
BE (1) BE811762A (xx)
CA (1) CA1036164A (xx)
CH (3) CH605619A5 (xx)
DD (2) DD113999A5 (xx)
DE (1) DE2409791C3 (xx)
ES (1) ES423789A1 (xx)
FR (1) FR2219787B1 (xx)
GB (1) GB1468347A (xx)
HU (1) HU169840B (xx)
IL (1) IL44320A (xx)
LU (1) LU69535A1 (xx)
NL (1) NL7402830A (xx)
ZA (1) ZA741232B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
DK1185267T3 (da) * 1999-06-10 2006-12-11 Bridge Pharma Inc Dermale bedövelsesmidler
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2008011161A2 (en) 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760018A (fr) * 1969-12-19 1971-06-08 Christiaens Sa A Nouveau derives du 2-amino-indane, leur preparation et leur utilisation
JPS4922702A (xx) * 1972-06-22 1974-02-28
JPS5216322B2 (xx) * 1972-06-22 1977-05-09

Also Published As

Publication number Publication date
ZA741232B (en) 1975-01-29
JPS547789B2 (xx) 1979-04-10
FR2219787A1 (xx) 1974-09-27
DE2409791B2 (de) 1978-11-16
LU69535A1 (xx) 1974-06-21
DE2409791A1 (de) 1974-09-12
DE2409791C3 (de) 1979-07-12
HU169840B (xx) 1977-02-28
IL44320A (en) 1977-06-30
CA1036164A (en) 1978-08-08
DD113999A5 (xx) 1975-07-12
AU6607074A (en) 1975-08-28
AT333742B (de) 1976-12-10
GB1468347A (en) 1977-03-23
AR206652A1 (es) 1976-08-06
ES423789A1 (es) 1976-05-16
FR2219787B1 (xx) 1978-01-06
NL7402830A (xx) 1974-09-04
IL44320A0 (en) 1974-05-16
CH593909A5 (xx) 1977-12-30
ATA170774A (de) 1976-04-15
DD112262A5 (xx) 1975-04-05
AR206653A1 (es) 1976-08-06
BE811762A (fr) 1974-09-02
CH593910A5 (xx) 1977-12-30
AR204526A1 (es) 1976-02-12
JPS5029543A (xx) 1975-03-25

Similar Documents

Publication Publication Date Title
AU450229B2 (xx)
FR2219787B1 (xx)
AU477823B2 (xx)
AU477824B2 (xx)
CH1211973A4 (xx)
CH567269A5 (xx)
CH566806A5 (xx)
CH566568A5 (xx)
CH565878A5 (xx)
CH565682A5 (xx)
CH564732A5 (xx)
CH564712A5 (xx)
CH563139A5 (xx)
CH563076A5 (xx)
CH567849A5 (xx)
CH562520A5 (xx)
CH562098A5 (xx)
CH560861A5 (xx)
CH567730A5 (xx)
BG22562A1 (xx)
BG19393A1 (xx)
BG19343A1 (xx)
BG19334A1 (xx)
AU480796A (xx)
AU479562A (xx)

Legal Events

Date Code Title Description
PL Patent ceased